A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod
| Autor: | Derek Stitt, Joseph P. Colgan, Eoin P. Flanagan, Christopher J. Boes, Matthew T. Howard |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Lymphoma B-Cell Multiple Sclerosis Skin Neoplasms Population MEDLINE 03 medical and health sciences 0302 clinical medicine Internal medicine Humans Medicine B-cell lymphoma education Aged education.field_of_study Disease surveillance Fingolimod Hydrochloride business.industry Potential risk Multiple sclerosis General Medicine medicine.disease Fingolimod Lymphoma Neurology Immunology Female Neurology (clinical) business Immunosuppressive Agents 030217 neurology & neurosurgery 030215 immunology medicine.drug |
| Zdroj: | Multiple Sclerosis and Related Disorders. 19:115-117 |
| ISSN: | 2211-0348 |
| DOI: | 10.1016/j.msard.2017.11.014 |
| Popis: | The authors report a case of a 69-year-old woman with multiple sclerosis treated with fingolimod for duration of over one year who subsequently developed cutaneous large B cell lymphoma. There are few reported cases of lymphoma associated with fingolimod treatment for multiple sclerosis, but rates are higher than expected in the general population. The authors hope to promote awareness of the potential risk of this medication so that more diligent disease surveillance can be performed by both prescribing practitioners of fingolimod and their patients who receive it. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect